Icon to employ AG Mednet’s cloud-based adjudication software

The Dublin-based CRO said it works with partners, academic research organizations, experts and opinion leaders to support data monitoring committees and event adjudication using the system. (Icon)

Icon signed an agreement with AG Mednet to use its electronic endpoint adjudication system to manage workflow and ensure data quality. The financial terms were not disclosed.

The contract research organization has previously used Boston-based AG Mednet’s cloud-based software, named Judi, for adjudicating thousands of events in therapeutic areas covering oncology, obesity and diabetes, Icon said in a statement.

“Judi provides a purpose-built solution for endpoint adjudication that enables efficient database set-up, data extraction and manages workflow effectively,” said Craig McLendon, senior director of adjudication and data monitoring committees management for Icon.


Like this story? Subscribe to FierceBiotech!

Biopharma is a fast-growing world where big ideas come along every day. Our subscribers rely on FierceBiotech as their must-read source for the latest news, analysis and data in the world of biotech and pharma R&D. Sign up today to get biotech news and updates delivered to your inbox and read on the go.

The Dublin-based CRO said it works with partners and academic research organizations, including over 400 experts and opinion leaders, to support data monitoring committees and event adjudication.

RELATED: Icon launches new electronic financial disclosure form software

“Icon has been an ideal partner in ensuring that both the development and the implementation of Judi meet the technical and clinical needs of investigator sites, CRO reviewers, adjudicators and clinical event committees,” said AG Mednet President and CEO Abraham Gutman.

Recently, Icon reached a preliminary agreement to use Intel’s pharmaceutical analytics platform in its clinical trials, which monitors, collects and helps analyze data from study participants using sensors, wearables and other mobile technologies. A smartphone app helps manage medications and submit patient-reported outcomes.

Suggested Articles

Oncology is clearly a major medical and societal issue, but one that sees too much focus from biopharmas at the expense of other killers.

The Mayo Clinic tapped data analytics firm nference to build out an AI-powered engine to collate its years of clinical records and pathology work.

At the annual J.P. Morgan Healthcare Conference, major CRO Charles River Laboratories and Takeda announced a new preclinical tie-up.